Research & Development
At PRI, we are engaged in three key areas of Research & Development:
- Drug Discovery at PRI reaches across therapeutic areas: hematology, oncology, cardiovascular, ophthalmology, vascular diseases, neurology, and inflammation.
- Drug Development at PRI includes drug formulation (particularly nanoformulation) and stability testing, leading to clinical trials.
- Nanotechnology/Biotechnology at PRI covers a wide range of applications. An example of PRI’s nanobiotechnology approach is targeted delivery of nanoparticles loaded with chemotherapeutic agents for pancreatic, brain, breast, prostate, ovarian, and lung cancer.
Learn more about how our research is helping to advance human health.Publications Page.